CorVent Medical
Private Company
Total funding raised: $27M
Overview
CorVent Medical is a private, commercial-stage medical device company targeting the respiratory support market with its ICU-standard RESPOND® ventilator. The company's value proposition centers on a streamlined, durable design that eliminates traditional service contracts, offers a 5-year warranty, and integrates connectivity for EHR and remote monitoring. It aims to address demand from acute, post-acute, and emergency stockpile settings by providing a cost-effective and easy-to-use alternative to complex, maintenance-heavy ventilators.
Technology Platform
ICU-standard mechanical ventilator platform (RESPOND®) designed for simplicity, durability, and connectivity. Features include invasive/non-invasive modes, pediatric-to-adult use, low-flow O2 source compatibility, integrated antiviral filters, remote monitoring (CorVision™), EHR integration, and a hot-swappable battery. Differentiated by a no-service-contract model and a standard 5-year warranty.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
The ventilator market is dominated by multinational giants like Medtronic, Philips, Getinge, and Vyaire, which offer comprehensive portfolios and global service contracts. CorVent's competition also includes more agile players like Zoll Medical (awarded BARDA contracts) and other startups. CorVent's primary competitive angles are its simplified, low-total-cost-of-ownership model, U.S. manufacturing, and focus on ease of use for non-ICU settings.